Matatiele Puleng, Tikly Mohamed, Tarr Gareth, Gulumian Mary
Toxicology & Biochemistry Research Section, National Institute for Occupational Health, National Health Laboratory Service, Johannesburg, South Africa.
Division of Rheumatology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
J Biomed Sci. 2015 May 20;22(1):34. doi: 10.1186/s12929-015-0142-2.
Systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) are systemic autoimmune connective tissue diseases that share overlapping clinico-pathological features. It is highly probable that there is an overlap in epigenetic landscapes of both diseases. This study aimed to identify similarities in DNA methylation changes in genes involved in SLE and SSc. Global DNA methylation and twelve genes selected on the basis of their involvement in inflammation, autoimmunity and/or fibrosis were analyzed using PCR arrays in three groups, each of 30 Black South Africans with SLE and SSc, plus 40 healthy control subjects.
Global methylation in both diseases was significantly lower (<25 %) than in healthy subjects (>30 %, p = 0.0000001). In comparison to healthy controls, a similar gene-specific methylation pattern was observed in both SLE and SSc. Three genes, namely; PRF1, ITGAL and FOXP3 were consistently hypermethylated while CDKN2A and CD70 were hypomethylated in both diseases. The other genes (SOCS1, CTGF, THY1, CXCR4, MT1-G, FLI1, and DNMT1) were generally hypomethylated in SLE whereas they were neither hyper- nor hypo-methylated in SSc.
SSc and SLE patients have a higher global hypomethylation than healthy subjects with specific genes being hypomethylated and others hypermethylated. The majority of genes studied were hypomethylated in SLE compared to SSc. In addition to the commonly known hypomethylated genes in SLE and SSc, there are other hypomethylated genes (such as MT-1G and THY-1) that have not previously been investigated in SLE and SSc though are known to be hypermethylated in cancer.
系统性红斑狼疮(SLE)和系统性硬化症(SSc)是具有重叠临床病理特征的系统性自身免疫性结缔组织疾病。这两种疾病的表观遗传格局很可能存在重叠。本研究旨在确定参与SLE和SSc的基因中DNA甲基化变化的相似性。使用PCR阵列分析了三组受试者的整体DNA甲基化情况以及基于其在炎症、自身免疫和/或纤维化中的作用而选择的12个基因,每组包括30名患有SLE和SSc的南非黑人,以及40名健康对照受试者。
两种疾病的整体甲基化水平均显著低于健康受试者(<25% 对比 >30%,p = 0.0000001)。与健康对照相比,SLE和SSc中观察到了相似的基因特异性甲基化模式。在两种疾病中,三个基因,即PRF1、ITGAL和FOXP3持续高甲基化,而CDKN2A和CD70低甲基化。其他基因(SOCS1、CTGF、THY1、CXCR4、MT1 - G、FLI1和DNMT1)在SLE中通常低甲基化,而在SSc中既不高甲基化也不低甲基化。
与健康受试者相比,SSc和SLE患者具有更高的整体低甲基化水平,特定基因低甲基化而其他基因高甲基化。与SSc相比,大多数研究的基因在SLE中低甲基化。除了SLE和SSc中常见的低甲基化基因外,还有其他低甲基化基因(如MT - 1G和THY - 1),虽然已知它们在癌症中高甲基化,但此前尚未在SLE和SSc中进行研究。